<SEC-DOCUMENT>0001104659-25-002269.txt : 20250110
<SEC-HEADER>0001104659-25-002269.hdr.sgml : 20250110
<ACCEPTANCE-DATETIME>20250110064721
ACCESSION NUMBER:		0001104659-25-002269
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250110

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TriSalus Operating Life Sciences, Inc.
		CENTRAL INDEX KEY:			0001518906
		ORGANIZATION NAME:           	
		IRS NUMBER:				270629393
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-94792
		FILM NUMBER:		25520300

	BUSINESS ADDRESS:	
		STREET 1:		6272 WEST 91ST AVENUE
		CITY:			WESTMINSTER
		STATE:			CO
		ZIP:			80031
		BUSINESS PHONE:		(888) 321-5212

	MAIL ADDRESS:	
		STREET 1:		6272 WEST 91ST AVENUE
		CITY:			WESTMINSTER
		STATE:			CO
		ZIP:			80031

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TriSalus Life Sciences, Inc.
		DATE OF NAME CHANGE:	20211001

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Surefire Medical, Inc.
		DATE OF NAME CHANGE:	20110425

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Utmost Group Plc
		CENTRAL INDEX KEY:			0002046077
		ORGANIZATION NAME:           	
		IRS NUMBER:				616132186
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		SADDLERS' HOUSE 5TH FLOOR,
		STREET 2:		44 GUTTER LANE,
		CITY:			LONDON
		STATE:			X0
		ZIP:			EC2V 6BR
		BUSINESS PHONE:		02038614361

	MAIL ADDRESS:	
		STREET 1:		SADDLERS' HOUSE 5TH FLOOR,
		STREET 2:		44 GUTTER LANE,
		CITY:			LONDON
		STATE:			X0
		ZIP:			EC2V 6BR
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Utmost Group Plc -->
          <cik>0002046077</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>12/30/2024</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001518906</issuerCik>
        <issuerName>TriSalus Life Sciences Inc.</issuerName>
        <issuerCusip>89680M101</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>6272 W. 91st Ave.</com:street1>
          <com:city>Westminster</com:city>
          <com:stateOrCountry>CO</com:stateOrCountry>
          <com:zipCode>80031</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Utmost Group PLC</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>X0</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>2000588.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>2000588.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2000588.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>6.56</classPercent>
      <typeOfReportingPerson>FI</typeOfReportingPerson>
      <comments>Lombard International Assurance S.A. was acquired by Utmost Group PLC on 30/12/2024. Shareholdings of Lombard International Assurance S.A. were disclosed on 21/10/2024, accession number 0001104659-24-110077</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>TriSalus Life Sciences Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>6272 W. 91st Ave. Westminster, CO, 80031</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Utmost Group PLC</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>Saddlers' House 5th Floor , 44 Gutter Lane, London, United Kingdom, EC2V 6BR</principalBusinessOfficeOrResidenceAddress>
        <citizenship>United Kingdom</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>N</notApplicableFlag>
        <typeOfPersonFiling>HC</typeOfPersonFiling>
      </item3>
      <item4>
        <amountBeneficiallyOwned>2,000,588 shares</amountBeneficiallyOwned>
        <classPercent>6.56</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>2,000,588</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>None</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>2,000,588</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>None</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>N</notApplicableFlag>
        <subsidiaryIdentificationAndClassification>Lombard International Assurance SA (acquired by Utmost Group on 30/12/2024)
4, rue Lou Hemmer L1748 Luxembourg</subsidiaryIdentificationAndClassification>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to (J) A non-U.S. institution that is the functional equivalent of any of the institutions listed in SS240.13d-1 (b)(1)(ii)(A) through (I), so long as the non-U.S. institution is subject to a regulatory scheme that is substantially comparable to the regulatory scheme applicable to the equivalent U.S. institution is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Utmost Group PLC</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Ian Maidens</signature>
        <title>Ian Maidens - Group CFO</title>
        <date>01/06/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
